US US20260014222A1
[0000] The present invention relates to an herbal composition and method for a treatment and management of at least one of hypertension, hyperlipidemia, diabetes mellitus, and associated cardiovascular risk factors. The composition comprises standardized plant extracts derived from Rauvolfia serpentina, Hippophae rhamnoides seed, Citrullus lanatus seed, and Phyllanthus emblica fruit, in approximate weight proportions ranging from 20-40% for Rauvolfia serpentina, 20-40% for Hippophae rhamnoides, 10-30% for Citrullus lanatus, and 10-30% for Phyllanthus emblica. The invention also provides a method of preparing the composition involving harvesting, drying, grinding, extracting with selected solvents, concentrating, optionally fractionating, and formulating into oral dosage forms such as one of capsules, tablets, and powder sachets. The invention further includes methods for administering the composition to a subject in need thereof, optionally as an adjunct to conventional therapy.
A document turning up in a search is not the same as a document that anticipates your claims. Our registered Patent Agents read the claims, not just the abstract, and tell you where you still have room.
Protect Your InventionBibliographic data via the European Patent Office's Open Patent Services (DOCDB) — republished here for research and prior-art review. This page is not legal advice, and its presence in our index says nothing about the validity or enforceability of the document. For the Indian legal position — status, oppositions, renewals — see InPASS.